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Abstract 
Lung transplantation is a necessary step for the patients with the end-stage of chronic obstructive 
pulmonary disease. The use of artificial lungs is a promising alternative to natural lung 
transplantation which is complicated and is restricted by low organ donations. For successful 
lung engineering, it is important to choose the correct combination of specific biological cells 
and a synthetic carrier polymer. The focus of this study was to investigate the interactions of 
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 2 
human lung epithelial cell line NCl-H292 that is involved in lung tissue development with the 
biodegradable poly(ɛ-caprolactone) before and after its chemical modification to evaluate 
potential for use in artificial lung formation. Also, the effect of polymer chemical modification 
on its mechanical and surface properties has been investigated. The poly(ɛ-caprolactone) surface 
was modified using aminolysis followed by immobilization of gelatine. The unmodified and 
modified polymer surfaces were characterized for roughness, tensile strength, and NCl-H292 
metabolic cell activity. The results showed for the first time the possibility for NCI-H292 cells to 
adhere on this polymeric material. The Resazurin assay showed that the metabolic activity at 
24 hours post seeding of 80% in the presence of the unmodified and greater than 100% in the 
presence of the modified polymer was observed. The roughness of the poly(ɛ-caprolactone) 
increased from 4 nm to 26 nm and the film strength increased from 0.01 kN to 0.045 kN when 
the material was chemically modified. The results obtained to date show potential for using 
modified poly(ɛ-caprolactone) as a scaffold for lung tissue engineering. 
Keywords: biopolymers, immobilization, tissue cell culture, tissue engineering, viability 
INTRODUCTION 
64 million people suffer from chronic obstructive pulmonary disease which is a cause of 
morbidity and mortality worldwide (Rabe, Hurd, and Anzueto 2007). The condition worsens 
gradually over time, starting usually with a shortness of breath and progressing to respiratory 
failure and eventually ends in death. There are three common methods to treat the end-stage lung 
failure caused by chronic obstructive pulmonary disease. Two of them, namely mechanical 
ventilation and extracorporeal membrane oxygenation, only provide a temporarily solution while 
waiting for the third treatment - lung transplantation (Lemon et al. 2013). However a full lung 
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 3 
transplant is an expensive procedure, limited by availability of donor organs, and goes 
accompanied by a high risk of post-operational complications. 
Fortunately, tissue engineering which brings together materials, cells and engineering, is 
offering the future possibility of alternative solution for lung transplantation. It is possible to 
fabricate a synthetic component composed of scaffold and biological cells which could take over 
natural lung functions. There are a number of materials that may be used as scaffolds for 
artificial lung preparation. The scaffold may be made by using the lungs from human cadavers 
by removing the cellular material from them and then seeding it with stem cells (Petersen et al. 
2010; Weiss et al. 2011). However, this is a very laborious and complicated way of regenerating 
tissue. An easier alternative is to use natural or synthetic polymers to produce the scaffolds for 
the artificial lungs (Seal, Otero, and Panitch 2001). Natural materials such as collagen, gelatin, or 
laminin (Liu et al. 1992; Andrade et al. 2007) interact with cells much better compared to 
synthetic materials due to their bioactive properties (Moscato et al. 2008; Gamez et al. 2012). 
Nevertheless the poor mechanical performance of the scaffolds made from natural polymers is 
considered being a drawback in lung tissue engineering. Polymeric biomaterials with excellent 
mechanical properties, a good degree of biodegrability, and compatibility to native tissue, 
represent good candidates for tissue formation (Lin et al. 2006). Among the synthetic polymers 
(Mihai et al. 2011), polyglycolic acid and Pluronic F-127 have been shown suitable materials for 
lung scaffolds (Cortiella et al. 2006). 
Poly(ε-caprolactone) has been commonly accepted as a biomaterial to be used in 
regenerative medicine because of its biodegradability properties and possible biocompatibility 
improvement. This biodegradable polymer has been commonly used in a number of applications 
such as bone regeneration (Zhou et al. 2006), trachea regeneration (Lin et al. 2011), and tissue 
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 4 
engineering of pulmonary artery (Matsumura et al. 2013). It has also been used as a drug carrier 
for drug delivery (Aqil et al. 2012; Li et al. 2012; Xu et al. 2014) and as a plain film in wound 
healing (Ng et al. 2007; Fu et al. 2014). A poly(ɛ-caprolactone) scaffold has been shown to 
support fibroblasts (Mei et al. 2005), human umbilical arterial smooth muscle cells (Hu et al. 
2014), endothelial cells (Guex et al. 2014), and mesenchymal stem cells (Zhao et al. 2014). 
Poly(ɛ-caprolactone) is known to produce less acidic products after hydrolysis under 
physiological conditions compared to other poly(ɛ-caprolactone) or polyglycolide polymers. This 
feature makes poly(ɛ-caprolactone) an attractive substrate for lung tissue engineering. 
The important requirement for the successful artificial lung development is the high 
degree of cell adhesion on the scaffold surface. Because of the hydrophobic nature of most of the 
polymers including poly(ɛ-caprolactone), modification of the material to improve its favorability 
for cell growth is necessary. One of the characteristics needed for scaffolds to support cell 
growth is biocompatibility (Gamez et al. 2012). Biocompatibility refers to the capability of a 
material to perform under physiological conditions without inducing toxic effects in the 
biological system (Lin et al. 2006; Moscato et al. 2008). To increase the biocompatibility of 
poly(ɛ-caprolactone), various methods have been developed (Ng et al. 2007; Yuan et al. 2012; 
De Luca, Terenghi, and Downes 2014) while at the same time the mechanical properties were 
maintained. Among these methods is aminolysis, which is easy to carry out and seems to bring 
many advantages (Zhu et al. 2002; Wang et al. 2009; Shaneh et al. 2015) such as reduced 
hydrophobicity of the surface, easy attachment of the biomolecules and consequently the 
possibility of cell growth on the surface, their adhesion, proliferation, and differentiation (Mei et 
al. 2005; Mota et al. 2014). 
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 5 
The presence of amine groups on the surface of polymer enables bonding of gelatin and 
later cells attachment. Gelatin is a naturally occurring protein which is derived from denaturation 
of collagen (Moscato et al. 2008; Tripathi, Kathuria, and Kumar 2009). It is a molecule which is 
combined with synthetic polymers to allow enhanced cell growth (Moscato et al. 2008). The 
reasons gelatin is selected for this purpose include the presence of functional groups (carbonyl 
groups) enhancing cell adhesion (Moscato et al. 2008); high viscosity and plasticity ( Tripathi, 
Kathuria, and Kumar 2009; Dhandyuthapani et al. 2011) improving mechanical properties of the 
final product; biodegradability ( Tripathi, Kathuria, and Kumar 2009; Dhandyuthapani et al. 
2011); biocompatibility (Moscato et al. 2008; Dhandyuthapani et al. 2011); and relatively low 
cost ( Tripathi, Kathuria, and Kumar 2009; Lim et al. 2011). Gelatin is naturally hydrophilic and 
its compatibility to natural tissue has been examined (Zhu et al. 2002). Most research indicates 
that the presence of gelatin increases cytocompatibility of the material. 
The material-cell interaction is influenced by surface topography. Atomic force 
microscopy (AFM) is a common technique for roughness measurement. The technique is based 
on obtaining a topographic image of the sample surface by scanning its surface in the x and y 
plane with a probe at the controlled distance (Raposo, Ferreira, and Ribeiro 2007). The quality of 
the AFM images are optimized with the software and quantitative analysis of the surface 
topography can be performed. The most common parameter used in characterizing the surface 
topography is the average roughness. It is the arithmetic average of the values of the deviations 
of the surface height taken from the mean plane. Another parameters used in quantitative 
analysis of atomic force microscopy data image very well described can be found here ( Raposo, 
Ferreira, and Ribeiro 2007). The roughness is widely used in the field of bioengineering. Zhang 
et al. reported that cell response was improved by increasing the roughness of the poly(lactic-co-
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 6 
glycolic) acid surface from 0.62 to 36.9 nm (Zhang, Chun, and Webster 2010). The other study 
showed that the adhesion and proliferation of human fetal osteoblasts was enhanced when the 
roughness of the material reached 15 nm (Lim et al. 2007). 
In vitro investigation of binding interactions between cells and carrier materials is a first 
step to help to assess biocompatibility before in vivo study. Compared to cells with limited 
lifetime, immortalized cell lines have indefinite possibility to be grown in culture which makes 
them suitable for in vitro analysis of biocompatibility of synthetic polymers (Altman, Randers, 
and Rao 1993; Zange, Li, and Kissel 1998; Huhtala et al. 2007; Singh, Wu, and Dunn 2011). 
Mammalian cell lines are used for such biocompatibility testing; normally a cell line of either 
human or mouse origin is used. The in vitro environment offers a setting to test the effects of the 
synthetic material on cell adhesion, proliferation, and viability (Huhtala et al. 2007). From this 
study, any cytotoxic effects related directly to the presence of the polymer may be assessed 
(Altman, Randers, and Rao 1993). In vitro models offer a relatively inexpensive, rapid method to 
provide initial biocompatibility screening that reduces the number of animal studies to be carried 
out (Zange, Li, and Kissel 1998; Huhtala et al. 2007). In this study, the cell line of choice was the 
human epithelial cell line NCI-H292. This line was derived from a lymph node metastasis of a 
pulmonary mucoepidermoid carcinoma. 
This paper investigates the interaction of human lung epithelial cell line NCl-H292 with a 
biodegradable poly(e-caprolactone) and poly(ɛ-caprolactone) modified with gelatin to consider 
its use as an implantable material for lung scaffold for treating chronic obstructive pulmonary 
disease. The cell compatibility of poly(ɛ-caprolactone) with the NCI-H292 cell line has not 
previously characterized in the literature. Similarly, the influence of polymer modification on 
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 7 
cell proliferation of the proposed material has not been assessed. The mechanical and structural 
properties of poly(ɛ-caprolactone) before and after modification are also be discussed. 
EXPERIMENTAL 
Preparation and Modification of Poly(ɛ-Caprolactone) Films 
Poly(ɛ-caprolactone) was prepared using a method previously reported by Yuan et al. 
(2012). Briefly, 1 ml of poly(ɛ-caprolactone) solution (1.5  10-3 mol/dm3) in dichloromethane 
was formed and deposited on a glass substrate. After removal of the solvent at room temperature, 
the glass substrates coated with thin film of poly(ɛ-caprolactone) were dried in a vacuum oven 
for 24 hours at 35C. The samples were then washed with deionized water and isopropanol 
followed by drying at room temperature for 12 hours in a vacuum oven. Then a well established 
surface modification method was used based on an aminolysis procedure described previously 
(Zhu et al. 2002). A 10% 1, 6-hexanediamine solution in isopropanol was prepared and heated at 
40C with poly(ɛ-caprolactone) films for 1 hour. The samples were then rinsed with deionized 
water followed by drying in a vacuum oven over night at 25C. Having amine groups on the 
surface, the next step was to attach gelatin to them. The samples were placed in 10 ml of 2.5 wt 
% glutaraldehyde solution in a phosphate buffer (pH 8) and the reaction was allowed to proceed 
for 12 hours at room temperature. The samples were rinsed with deionised water and the films 
were placed in 50 ml of 3 mg/ml gelatin in phosphate buffer with continuous stirring for 
24 hours at room temperature. The samples coated with gelatin were washed with deionized 
water and phosphate buffer for 14 hours. 
Surface Characterisation of the Poly (ɛ-Caprolactone) Films 
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 8 
In this study we have used a Veeco multimode V atomic force microscope in tapping 
mode to investigate the morphology before and after the surface modification with gelatin via 
aminolysis process. The surface properties of the material influence the interactions between the 
cells and the material (Lim et al. 2007; Zhang, Chun, and Webster 2010). Infrared spectroscopy 
was used to verify the presence of amine groups and gelatin on the surface of the poly(ɛ-
caprolactone) films using a Spectrum One Fourier transform spectrometer, (PerkinElmer, USA). 
Mechanical Characterization 
The mechanical strength of poly(ɛ-caprolactone) before and after modification with 
gelatin was investigated. The comparison between mechanical properties of unmodified and 
modified poly(ɛ-caprolactone) was analysed. Tensile tests were done using an Instron model 
5565 Universal Electromechanical test system instrument. The test was done at a constant 
extension rate of 1 mm/min, and the tensile force applied to the specimens (with 10 mm diameter 
disk shape) was recorded by a 500 N load cell. The test was complete upon sample failure. 
Preparation of Polymers for Cell Culture 
The polymers were immersed in isopropanol and placed in a sonicator for twenty 
minutes. The isopropanol was removed and the polymers were rinsed 8 to 10 times with 
deionized water. The twenty minute sonication was repeated using deionized 18.2 Ω water. The 
polymers were dried under nitrogen prior to being oxygen plasma (Harrick Plasma) treated at 
100 W for twenty minutes. 
Cell Culture 
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NCI-H292 cells were cultured in sterile growth medium. The basal media RPMI- 1640 
media was used. This was supplemented with 10% fetal bovine serum (Sigma, Ireland) and 
stored at 4°C for up to six weeks. Hank’s balanced salt solution without calcium and magnesium 
(Sigma, Ireland) was used in the culturing process as a rinsing agent. Trypsin /EDTA (Sigma, 
Ireland) was used to detach the cells from the surface of the tissue culture flask. The process first 
involved removal of spent media that was discarded. The flask was rinsed gently with 10mls 
warmed Hank’s balanced salt solution twice. 3 ml of warmed trypsin-EDTA were added and the 
flask was incubated for twenty minutes at 37oC. An excess of warmed routine media (7 ml) was 
added and centrifuged at 1000 rpm for five minutes. Supernatant was separated and discarded. 
The pellet was resuspended in routine media and transferred to new flask with a subcultivation 
ratio of 1/3 to 1/8. A final volume of 30 ml media was required. Media renewal was performed 
every two to three days. The cells were grown at 37 °C in a humidified 95% air/5% CO2 
environment. 
Cell Count-Trypan Blue Exclusion Assay 
The Trypan blue exclusion assay is employed to verify the percentage of viable cells that 
a suspension contains. The basis for this test is that live cells due to an intact cell membrane will 
exclude Trypan blue dye, whereas dead cells have lost their membrane permeability barrier and 
so do not exclude the dye (Altman, Randers, and Rao 1993). After exposure to Trypan blue, live 
cells appear white and dead cells appear blue upon microscopic examination (Altman, Randers, 
and Rao 1993). Equal volumes of Trypan blue stain and cell suspension were mixed. Cells were 
counted using a hemocytomer. This is used to determine the quality of the cell suspension prior 
to use in an experiment. NCI-H292 cells used showed a cell viability of ≥95%. 
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Exposure Assay 
NCI-H292 cells were seeded in a twenty four well plates at 70,000 cells/well in the 
presence and absence of the test polymers (modified and unmodified polymers were tested). The 
plate was placed in the incubator for 1 hour to allow cell attachment prior to the volume in each 
well being made up to a final volume of 1ml in each well. The plate was incubated for an 
additional 24 hours and the cell viability was determined spectrophotometrically. Excitation was 
performedat 445 nm and emission at 590 nm with the Resazurin assay and cell morphologic 
changes were analyzed microscopically. 
Optical Analysis-Cell Morphology 
The images of the cells were taken using an inverted phase microscope (Olympus 
CKX41) with a 100× magnification. Qualitative biocompatibility analysis was carried out by 
comparing the morphology of NCI-H292 cells cultured in the presence of modified and 
unmodified polymers to control samples. 
RESULTS AND DISCUSSION 
Preparation and Characterisation of the Functionalised Poly(ɛ-Caprolactone) 
Film 
The natural hydrophobic properties of poly(ɛ-caprolactone) and absence of a bioactive 
functional group (Domb et al. 1997) on its surface restricts its application for tissue engineering 
by decreasing its biocompatibility. To enable attachment of gelatin to the surface of poly(ɛ-
caprolactone), it was necessary to provide polymer surface with functional groups; in this case, 
amine groups to which gelatin could bond. 
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Figure 1 presents infrared spectra obtained of poly(ɛ-caprolactone) surfaces before and 
after amine attachment and gelatin immobilization. Poly(ɛ-caprolactone) included characteristic 
peaks at 2800 and 2900 cm -1 due to symmetric and asymmetric CH2 stretching. The absorption 
at 1726 cm-1 represents the presence of carbonyl groups while the peak at 1299 cm-1 is from C-
O and C-C groups (Yuan et al. 2012). Figure 1b includes absorption at 3521, 1650, and 
1550 cm-1 characteristic for amide I (N–H), C=O, and amide II N-H. Figure 1c includes shifts in 
the amide I peak to 1650 cm-1 and amide II band to 1550 cm-1, indicating immobilization of 
gelatin on the surface of the poly(ɛ-caprolactone)-NH2. These results are comparable to those 
obtained by Yuan et al. (2012) and confirm the surface modification of poly(ɛ-caprolactone) with 
gelatin. 
Further investigation of the poly(ɛ-caprolactone) film before and after chemical 
modification was carried out using atomic force microscopy to characterize the surface 
roughness. The biological response of cells to polymeric material is influenced by number of 
factors including roughness of the material (Chang 2011) (Yuan et al. 2012). It is important to 
note that the cell response to roughness varies depending on the cell type. 
Figure 2 shows the representative atomic force micrographs of the unmodified and 
modified poly(ɛ-caprolactone) surfaces. The uniform and smooth surface has been observed in 
the unmodified poly(ɛ-caprolactone) film. The surface roughness was 4 nm (Figure 2a). The 
surface roughness value increased to 26 nm (Figure 2b) after aminolysis treatment and gelatin 
immobilization. The observation that this chemical modification caused an increase in the 
surface roughness was also reported by Yuan et al. (2012). The increased surface roughness is 
expected to enhance the performance of the material due to increased surface area available for 
cell interaction (Lim et al. 2007; Zhang, Chun, and Webster 2010) 
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Mechanical Properties 
The material for lung scaffolds should be mechanically strong and flexible to assure 
successful transplantation and functioning. One of the reasons that poly(ɛ-caprolactone) is 
widely used for tissue engineering is the favorable mechanical properties of the material. Most 
reported work on mechanical properties of poly(ɛ-caprolactone) involves poly(ɛ-caprolactone) 
composites (Niu et al. 2014; Cocca et al. 2015; Kim et al. 2015) or poly(ɛ-caprolactone) 
modified with gelatine without early introduction of amine groups (Zhang et al. 2005; Zhoua et 
al. 2011; Duan et al. 2013). Although aminolysis is often employed to increase the 
biocompatibility of poly(ɛ-caprolactone) as reported in the literature (Zhu et al. 2002; Wang et 
al. 2009; Yuan et al. 2012; Shaneh et al. 2015), there is no study characterizing the influence of 
this process on the mechanical properties of the poly(ɛ-caprolactone). Also, the effects are 
unknown when gelatine is immobilized on its surface. It is important to ensure that poly (ɛ-
caprolactone) does not lose its strength after modifications to its surface. For this reason, tensile 
tests were performed before and after modification. 
The difference in mechanical behavior between unmodified and modified poly(ɛ-
caprolactone) is shown in Figure 3. The modified poly(ɛ-caprolactone) requires a higher force to 
break the film than the unmodified poly(ɛ-caprolactone) with a difference of 6 N. However, 
while the modification makes the poly(ɛ-caprolactone) stronger, its stretching ability is reduced 
compared to the unmodified poly(ɛ-caprolactone). The modified poly(ɛ-caprolactone) was 
observed to be stiff, brittle, and less strong compared to unmodified poly(ɛ-caprolactone) which 
is more flexible and ductile and breaks at less than half the strength (0.0045 kN) of modified 
poly(ɛ-caprolactone) . Ideally, a compromise should be obtained, with reduced strength but with 
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more flexibility. Mechanical strength of the material is an advantage for scaffolds in artificial 
lung engineering, while flexibility accommodates the breathing action of the lungs. 
In Vitro Cell Culture 
The biocompatibility of a material indicates that the material after contact with a living 
organism is not toxic. The biocompatibility of modified and unmodified poly(ɛ-caprolactone) 
was evaluated in vitro using the resazurin assay and by cell morphology investigation of the cells 
cultured in direct contact with poly(ɛ-caprolactone). The resazurin assay was performed to 
measure the reduction of the blue non-fluorescent 1,2,3 resazurin dye (7-hydroxy-3H-
phenoxazin-3-one-10-oxide) to pink fluorescent resorufin by metabolically active cells indicating 
cell viability. The reduction of resazurin correlates with the number of live mammalian cells 
present (Zange, Li, and Kissel 1998; Strober 2001; Weaver et al. 2010; Cavet et al. 2012). The 
reduction was quantified by spectrophotometrical measurements at 445 nm and emission at 
590 nm. The results for the poly(ɛ-caprolactone) cell proliferation test, modified and unmodified, 
are presented in Figure 4. When the cells were incubated with modified poly(ɛ-caprolactone), 
the viability of the sample (103%) slightly exceeded the control (100%) and unmodified poly(ɛ-
caprolactone) (80%). Due to the nature of the assay, it was possible to have viability greater than 
100% when comparing with the positive control. The control was used as an indication of cell 
growth and a benchmark for ensuring that the cells were healthy and responding properly to their 
environment. If the control was affected by the assay, it would signal that something else was 
causing the cells to undergo a cytotoxic response as opposed to the material or surface that the 
cells where being cultured on. This test indicates that the modified poly(ɛ-caprolactone) samples 
did not induce cytotoxic effects and increase cell proliferation. Both poly(ɛ-caprolactone) 
samples provided acceptable biocompatibility compared with the control. The modied poly(ɛ-
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caprolactone) caused a slight increase in cell viability compared to the control and a larger 
increase in viability when compared to the unmodified sample. The results confirmed the 
biocompatibility of the modified poly(ɛ-caprolactone) and the positive effect on cell behaviour. 
These results also showed for the first time that human lung epithelial type NCI-H292 cells may 
adhere to and proliferate on the poly(ɛ-caprolactone) material. 
To analyze the cell morphology, images were taken from modified and unmodified 
poly(ɛ-caprolactone), as shown in Figure 5. The results showed that the cells demonstrated the 
same characteristics after incubation with both poly(ɛ-caprolactone) samples. No obvious 
morphological differences between the unmodified poly(ɛ-caprolactone) and modified poly(ɛ-
caprolactone) samples were apparent using thane inverted phase microscope with a 100× 
magnification. The results confirmed biocompatibility of the modified poly(ɛ-caprolactone) and 
positive effects on cell behavior and that human lung epithelial cells may adhere to and 
proliferate on poly(ɛ-caprolactone). 
CONCLUSIONS 
Poly(ɛ-caprolactone) is widely used in regenerative medicine with many applications in 
tissue engineering. Here an application has been added with a successful evaluation to use 
poly(ɛ-caprolactone) as a lung scaffold for chronic obstructive pulmonary disease. 
The aminolysis, as previously reported (Zhu et al. 2002), is an easy to employ chemical 
process that has been used to increase the biocompatibility of poly(ɛ-caprolactone). Accordingly, 
integration between the scaffold material and the lung cells is crucial for tissue formation. Here, 
a poly(ɛ-caprolactone) modification (Zhu et al. 2002) was employed for the human epithelial cell 
line NCI-H292. Unlike previous work on poly(ɛ-caprolactone) material modified with gelatin by 
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aminolysis, this work focused on structural and mechanical properties, and showed the 
possibility of using the material for the chronic obstructive pulmonary disease. 
Gelatin was immobilized on poly(ɛ-caprolactone) surface with the amine groups. The 
modification of poly(ɛ-caprolactone) increased the strength of the material, but with the loss of 
flexibility, and increased the biocompatibility of the material. Both poly(ɛ-caprolactone) samples 
did not present cytotoxic effects and the cells spread well as observed by optical microscopy. 
Cell proliferation on the modified poly(ɛ-caprolactone) increased compared to the unmodified 
film. Table 1 summarizes the properties of modified and unmodified poly(ɛ-caprolactone). 
Poly(ɛ-caprolactone) modification with gelatin was shown for the first time to not 
negatively affect the spreading of human epithelial cell line NCI-H292 cells and increased 
metabolic activity at 24 hours post seeding to 103% compared to control samples. The results 
show that poly(ɛ-caprolactone) modified with gelatin is a promising material for lung scaffold 
engineering. In order to provide a reliable polymeric material for successful artificial lung 
development, the lifetime prediction of the polymer in natural environment must be investigated. 
This parameter will be evaluated in future work. 
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Table 1. Summary of poly(ɛ-caprolactone) properties before and after chemical modification 
with amine groups and gelatin 
Parameter Unmodified poly(ɛ-
caprolactone) 
Modified poly(ɛ-caprolactone) 
Biocompatibility Yes Yes 
Applied force at which the 
film breaks 
0.006 kN 0.012 kN 
Surface roughness 4 nm 26 nm 
Cytotoxicity No No 
Viability 80% 103% 
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Figure 1. Infrared spectra of (a) poly(ɛ-caprolactone), (b) poly(ɛ-caprolactone) after aminolysis, 
and (c) poly(ɛ-caprolactone) after aminolysis and immobilization with gelatin. 
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Figure 2. Atomic force micrographs of (a) unmodified poly(ɛ-caprolactone) and (b) modified 
poly(ɛ-caprolactone). 
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Figure 3. Load-extension curves of unmodified and modified poly(ɛ-caprolactone). 
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Figure 4. Cell viability in presence of unmodified and modified poly(ɛ-caprolactone) extracted 
after 24 hours of culture. For modified samples, n = 3; for unmodified samples n = 4. Statistical 
comparison was made using a one sample Student's t-test. A value of p < 0.05 was considered to 
indicate statistical significance. All results were shown to be statistically significant; p < 0.001. 
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Figure 5. Images of cell cultures obtained following 24 hours for (a) unmodified poly(ɛ-
caprolactone) and (b) modified poly(ɛ-caprolactone) using an inverted phase microscope with 
100× magnification. 
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